Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma - ScienceDirect
Development and Validation of a Prediction Model of Overall Survival in High-Risk Neuroblastoma Using Mechanistic Modeling of Metastasis | JCO Clinical Cancer Informatics
Neuroblastoma | Radiology Key
Kaplan–Meier overall survival curves for patients with neuroblastoma... | Download Scientific Diagram
Clinical Features of Neuroblastoma with 11q Deletion: An Increase in Relapse Probabilities in Localized and 4S Stages | Scientific Reports
A single center clinical analysis of children with neuroblastoma
Cancers | Free Full-Text | Urokinase Receptor uPAR Downregulation in Neuroblastoma Leads to Dormancy, Chemoresistance and Metastasis
Overall survival of neuroblastoma patients depending on the N-Myc... | Download Scientific Diagram
Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma - ScienceDirect
Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma | PLOS ONE
A deeper look at the recent DFMO paper... - Beat Childhood Cancer
Neuroblastoma - TeachMePaediatrics
Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma | Scientific Reports
Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979–2015 | SpringerLink
Treatment and outcomes of 1041 pediatric patients with neuroblastoma who received multidisciplinary care in China | Pediatric Investigation
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset | PNAS
Prognostic significance of MYCN related genes in pediatric neuroblastoma: a study based on TARGET and GEO datasets. - Abstract - Europe PMC
Neuroblastoma
Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid | NEJM
Clinico-epidemiology of neuroblastoma in north east Egypt: A 5-year multicenter study
Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma - eClinicalMedicine
Kaplan–Meier curves for neuroblastoma patients with and without TIAM1... | Download Scientific Diagram
Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma | NEJM
Cancers | Free Full-Text | Anti-GD2 Based Immunotherapy Prevents Late Events in High-Risk Neuroblastoma Patients over 18 Months at Diagnosis
Figure 2 from Advances in Risk Classification and Treatment Strategies for Neuroblastoma. | Semantic Scholar
CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS AND SURVIVAL OUTCOMES OF CHILDREN WITH NEUROBLASTOMA: 21 YEARS OF EXPERIENCE AT THE INSTITUTO DE ONCOLOGIA PEDIÁTRICA, IN SÃO PAULO, BRAZIL. - Abstract - Europe PMC
